Author

J. L. Miller

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Assay:imaging· 1

Frequent Co-Authors

A. Alasonyalilar Demirer· 1 shared A. Zubair· 1 shared A.-C. Girard· 1 shared B. L. Kimball· 1 shared C. Lindskog· 1 shared C. M. Stewart· 1 shared C. Manriquez-Roman· 1 shared C. Olpe· 1 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Alasonyalilar Demirer

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

PTEN and ARID1A haploinsufficiency equip colonic epithelium for oncogenic transformation

N. Skoufou-Papoutsaki, S. Adler, S. Mehmed, C. Tume, C. Olpe, E. Morrissey, R. Kemp, A.-C. Girard, E. B. Moutin, C. S. R. Chilamakuri, J. L. Miller, C. Lindskog, F. Werle, K. Marks, F. Perrone, , D. J. Winton

The paper investigates how PTEN and ARID1A haploinsufficiency in colonic epithelium contributes to oncogenic transformation by altering clone dynamics and creating a pro-tumorigenic microenvironment.

bioRxiv · Mar 27, 2024 · PreprintCancer Biology

Optimized CART Cell Therapy for Metastatic Aggressive Thyroid Cancer

C. Manriquez-Roman, E. L. Siegler, J. J. Gleba, T. N. Huynh, G. E. DeFranco, A. Alasonyalilar Demirer, M. L. Pawlush, M. Redig, S. M. Klinge, L. K. Mai, J. L. Miller, E. E. Miller, B. L. Kimball, E. E. Tapper, R. L. Sakemura, , S. S. Kenderian

This paper develops a TSHR-targeted CART cell therapy for thyroid cancer and shows that combining it with MAPK inhibitors improves antitumor efficacy in dedifferentiated thyroid cancers.

bioRxiv · Mar 15, 2024 · PreprintImmunology